enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NVNO is expected to report earnings to fall 5.71% to -33 cents per share on November 29
Q3'24
Est.
$-0.33
Q4'24
Est.
$-0.35
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.09
Q4'23
Beat
by $0.22
The last earnings report on February 27 showed earnings per share of -34 cents, meeting the estimate of -34 cents. With 22.97K shares outstanding, the current market capitalization sits at 72.44M.